全文获取类型
收费全文 | 147938篇 |
免费 | 10822篇 |
国内免费 | 606篇 |
专业分类
耳鼻咽喉 | 1734篇 |
儿科学 | 3619篇 |
妇产科学 | 2834篇 |
基础医学 | 20870篇 |
口腔科学 | 3654篇 |
临床医学 | 15544篇 |
内科学 | 31134篇 |
皮肤病学 | 2569篇 |
神经病学 | 15405篇 |
特种医学 | 5818篇 |
外国民族医学 | 6篇 |
外科学 | 20466篇 |
综合类 | 1563篇 |
一般理论 | 116篇 |
预防医学 | 11154篇 |
眼科学 | 2470篇 |
药学 | 10178篇 |
1篇 | |
中国医学 | 169篇 |
肿瘤学 | 10062篇 |
出版年
2023年 | 805篇 |
2022年 | 612篇 |
2021年 | 2777篇 |
2020年 | 2011篇 |
2019年 | 2886篇 |
2018年 | 3538篇 |
2017年 | 2801篇 |
2016年 | 3299篇 |
2015年 | 3718篇 |
2014年 | 4900篇 |
2013年 | 6675篇 |
2012年 | 10237篇 |
2011年 | 10474篇 |
2010年 | 6201篇 |
2009年 | 5683篇 |
2008年 | 9058篇 |
2007年 | 9888篇 |
2006年 | 9044篇 |
2005年 | 9040篇 |
2004年 | 8380篇 |
2003年 | 7611篇 |
2002年 | 7327篇 |
2001年 | 2252篇 |
2000年 | 2082篇 |
1999年 | 2007篇 |
1998年 | 1482篇 |
1997年 | 1217篇 |
1996年 | 993篇 |
1995年 | 1139篇 |
1994年 | 973篇 |
1993年 | 924篇 |
1992年 | 1362篇 |
1991年 | 1289篇 |
1990年 | 1206篇 |
1989年 | 1180篇 |
1988年 | 1046篇 |
1987年 | 970篇 |
1986年 | 1000篇 |
1985年 | 1030篇 |
1984年 | 837篇 |
1983年 | 737篇 |
1982年 | 737篇 |
1981年 | 607篇 |
1980年 | 524篇 |
1979年 | 625篇 |
1978年 | 519篇 |
1977年 | 490篇 |
1975年 | 431篇 |
1974年 | 434篇 |
1973年 | 406篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Kari Hemminki Kristina Sundquist Jan Sundquist Asta Försti Vaclav Liska Akseli Hemminki Xinjun Li 《International journal of cancer. Journal international du cancer》2023,152(6):1107-1114
Many environmental risk factors for hepatobiliary cancers are known but whether they are associated with specific cancer types is unclear. We present here a novel approach of assessing standardized incidence ratios (SIRs) of previously diagnosed comorbidities for hepatocellular carcinoma (HCC), gallbladder cancer (GBC), cholangiocarcinoma (CCA) and ampullary cancer. The 13 comorbidities included alcohol and nonalcohol related liver disease, chronic obstructive pulmonary disease, gallstone disease, viral and other kinds of hepatitis, infection of bile ducts, hepatic and other autoimmune diseases, obesity and diabetes. Patients were identified from the Swedish Inpatient Register from 1987 to 2018, and their cancers were followed from 1997 onwards. SIRs for HCC were 80 to 100 in men and women diagnosed with hepatitis C virus and they were also >10 in patients diagnosed with hepatitis B virus, other kind of hepatitis, hepatic autoimmune disease and nonalcohol related liver disease. Many of these risks, as well as alcohol related liver disease, were either specific to HCC or were shared with intrahepatic CCA. For GBC, CCA and ampullary cancer infection of bile ducts was the main risk factor. Gallstone disease, nonhepatic autoimmune diseases and diabetes were associated with all hepatobiliary cancers. The limitations of the study include inability to cover some rare risk factors and limited follow-up time. Many of the considered comorbidities are characterized by chronic inflammation and/or overt immune disturbance in autoimmune diseases. The results suggest that local chronic inflammation and a related immune disturbance is the carcinogenic trigger for all these cancers. 相似文献
2.
Härter Martin Koch-Gromus Uwe 《Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz》2022,65(3):267-269
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz - 相似文献
3.
Jana Kristin Eckert Julia Kahle Andreas Bck Kathrin Zeber Kathrin Urner Wolfgang Greiner Simone Kreimeier Kirsten Beyer Josefine Dobbertin-Welsch Eckard Hamelmann Ines Gellhaus Christina Schorlemer Michael Kabesch Parastoo Kheiroddin Erika von Mutius Martin Depner Daniel Walter Gesine Hansen Stephanie DeStefano Sabine Schnadt Bianca Schaub 《Pediatric allergy and immunology》2022,33(1):e13652
4.
5.
6.
Andreas Lundin Martin Annborn Ola Borgquist Joachim Düring Johan Undén Christian Rylander 《Acta anaesthesiologica Scandinavica》2023,67(5):655-662
Patients admitted to intensive care after cardiac arrest are at risk of circulatory shock and early mortality due to cardiovascular failure. The aim of this study was to evaluate the ability of the veno-arterial pCO2 difference (∆pCO2; central venous CO2 – arterial CO2) and lactate to predict early mortality in postcardiac arrest patients. This was a pre-planned prospective observational sub-study of the target temperature management 2 trial. The sub-study patients were included at five Swedish sites. Repeated measurements of ∆pCO2 and lactate were conducted at 4, 8, 12, 16, 24, 48, and 72 h after randomization. We assessed the association between each marker and 96-h mortality and their prognostic value for 96-h mortality. One hundred sixty-three patients were included in the analysis. Mortality at 96 h was 17%. During the initial 24 h, there was no difference in ∆pCO2 levels between 96-h survivors and non-survivors. ∆pCO2 measured at 4 h was associated with an increased risk of death within 96 h (adjusted odds ratio: 1.15; 95% confidence interval [CI]: 1.02–1.29; p = .018). Lactate levels were associated with poor outcome over multiple measurements. The area under the receiving operating curve to predict death within 96 h was 0.59 (95% CI: 0.48–0.74) and 0.82 (95% CI: 0.72–0.92) for ∆pCO2 and lactate, respectively. Our results do not support the use of ∆pCO2 to identify patients with early mortality in the postresuscitation phase. In contrast, non-survivors demonstrated higher lactate levels in the initial phase and lactate identified patients with early mortality with moderate accuracy. 相似文献
7.
Wienhold Jan Kemper Ilka Czaplik Michael Follmann Andreas Rossaint Rolf Derwall Matthias 《Der Anaesthesist》2023,72(10):697-702
Die Anaesthesiologie - In Deutschland werden pro Jahr 17 Millionen Narkosen und damit auch ungefähr so viele Narkosevorgespräche durchgeführt. Bis dato finden diese praktisch... 相似文献
8.
9.
Die Anaesthesiologie - Simulationstraining ist für die Notfallmedizin unverzichtbar, insbesondere in Hinsicht auf eine verbesserte Patientensicherheit. Methoden und Technologien umfassen ein... 相似文献
10.
Steven P. Rowe MD PhD Martin G. Pomper MD PhD 《CA: a cancer journal for clinicians》2022,72(4):333-352
The authors define molecular imaging, according to the Society of Nuclear Medicine and Molecular Imaging, as the visualization, characterization, and measurement of biological processes at the molecular and cellular levels in humans and other living systems. Although practiced for many years clinically in nuclear medicine, expansion to other imaging modalities began roughly 25 years ago and has accelerated since. That acceleration derives from the continual appearance of new and highly relevant animal models of human disease, increasingly sensitive imaging devices, high-throughput methods to discover and optimize affinity agents to key cellular targets, new ways to manipulate genetic material, and expanded use of cloud computing. Greater interest by scientists in allied fields, such as chemistry, biomedical engineering, and immunology, as well as increased attention by the pharmaceutical industry, have likewise contributed to the boom in activity in recent years. Whereas researchers and clinicians have applied molecular imaging to a variety of physiologic processes and disease states, here, the authors focus on oncology, arguably where it has made its greatest impact. The main purpose of imaging in oncology is early detection to enable interception if not prevention of full-blown disease, such as the appearance of metastases. Because biochemical changes occur before changes in anatomy, molecular imaging—particularly when combined with liquid biopsy for screening purposes—promises especially early localization of disease for optimum management. Here, the authors introduce the ways and indications in which molecular imaging can be undertaken, the tools used and under development, and near-term challenges and opportunities in oncology. 相似文献